These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1683227)

  • 1. Molecular mechanisms of nitrovasodilator bioactivation.
    Noack E; Feelisch M
    Basic Res Cardiol; 1991; 86 Suppl 2():37-50. PubMed ID: 1683227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Explanation of the discrepancy between the degree of organic nitrate decomposition, nitrite formation and guanylate cyclase stimulation.
    Feelisch M; Noack E; Schröder H
    Eur Heart J; 1988 Jan; 9 Suppl A():57-62. PubMed ID: 2900766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanylate cyclase activation by organic nitrates is not mediated via nitrite.
    Romanin C; Kukovetz WR
    J Mol Cell Cardiol; 1988 May; 20(5):389-96. PubMed ID: 2905390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of action of nitrates with regard to vasodilatation and tolerance.
    Kukovetz WR; Holzmann S
    Z Kardiol; 1986; 75 Suppl 3():8-11. PubMed ID: 2879392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a correlation between nitric oxide formation by cleavage of organic nitrates and activation of guanylate cyclase.
    Schröder H; Noack E; Müller R
    J Mol Cell Cardiol; 1985 Sep; 17(9):931-4. PubMed ID: 2864457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of aldehyde dehydrogenase to mitochondrial bioactivation of nitroglycerin: evidence for the activation of purified soluble guanylate cyclase through direct formation of nitric oxide.
    Kollau A; Hofer A; Russwurm M; Koesling D; Keung WM; Schmidt K; Brunner F; Mayer B
    Biochem J; 2005 Feb; 385(Pt 3):769-77. PubMed ID: 15377279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.
    Feelisch M; Noack EA
    Eur J Pharmacol; 1987 Jul; 139(1):19-30. PubMed ID: 2888663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols.
    Ignarro LJ; Gruetter CA
    Biochim Biophys Acta; 1980 Aug; 631(2):221-31. PubMed ID: 6105889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite.
    Gruetter CA; Kadowitz PJ; Ignarro LJ
    Can J Physiol Pharmacol; 1981 Feb; 59(2):150-6. PubMed ID: 6112057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of vasodilation by nitrates: role of cyclic GMP.
    Kukovetz WR; Holzmann S; Romanin C
    Cardiology; 1987; 74 Suppl 1():12-9. PubMed ID: 2886220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses.
    Mülsch A; Busse R; Bassenge E
    Eur J Pharmacol; 1988 Dec; 158(3):191-8. PubMed ID: 2908105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
    Mülsch A; Busse R; Bassenge E
    Z Kardiol; 1989; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activation of soluble guanylyl cyclase and nitric oxide release: a comparison of NO donors and NO mimetics.
    Artz JD; Toader V; Zavorin SI; Bennett BM; Thatcher GR
    Biochemistry; 2001 Aug; 40(31):9256-64. PubMed ID: 11478893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity.
    Gerzer R; Karrenbrock B; Siess W; Heim JM
    Thromb Res; 1988 Oct; 52(1):11-21. PubMed ID: 2904706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans.
    Feelisch M; Schönafinger K; Noack E
    Biochem Pharmacol; 1992 Sep; 44(6):1149-57. PubMed ID: 1358072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide inhibits vascular bioactivation of glyceryl trinitrate: a novel mechanism to explain preferential venodilation of organic nitrates.
    Kojda G; Patzner M; Hacker A; Noack E
    Mol Pharmacol; 1998 Mar; 53(3):547-54. PubMed ID: 9495823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of NO release from sydnonimines.
    Feelisch M; Ostrowski J; Noack E
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S13-22. PubMed ID: 2484692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent findings on nitrates: their action, bioactivation and development of tolerance].
    Münzel T
    Dtsch Med Wochenschr; 2008 Oct; 133(44):2277-82. PubMed ID: 18946854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
    Marks GS; McLaughlin BE; Jimmo SL; Poklewska-Koziell M; Brien JF; Nakatsu K
    Drug Metab Dispos; 1995 Nov; 23(11):1248-52. PubMed ID: 8591726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human endothelial cells bioactivate organic nitrates to nitric oxide: implications for the reinforcement of endothelial defence mechanisms.
    Feelisch M; Brands F; Kelm M
    Eur J Clin Invest; 1995 Oct; 25(10):737-45. PubMed ID: 8557060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.